SMOC1 and lung carcinoma: Our retrospective study of lung cancer patient tissues corroborates the in vitro findings to enable molecular precision in defining PKR and OAS as critical tumor-suppressors of lung carcinogenesis (Figure 7B,C), and that their deficiency, as observed in the later stages of lung cancer patient tissues, likely provoked the advancement of the disease (Figure 7B,C).